Skip to main content

Warning notification:Warning

Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:

  1. Chrome
  2. Edge
  3. FireFox
  4. Opera
  5. Safari
HSE National Clinical Guideline

HSE National Clinical Guideline for the Diagnosis and Treatment of Breast Implant Associated – Anaplastic Large Cell Lymphoma (BIA-ALCL)


Topic: Diagnosis and treatment of breast implant associated – anaplastic large cell lymphoma (bia-alcl)
Document Owner: National Clinical Advisor for Plastic Surgery, National Clinical Programme in Surgery
National Group: National Clinical Programme in Surgery
Effective From: 07 September 2024
This Clinical Guideline will support the diagnosis and treatment of individuals presenting with concerns or symptoms associated with BIA-ALCL.
HSE National Clinical Guideline for the Diagnosis and Treatment of Breast Implant Associated – Anaplastic Large Cell Lymphoma (BIA-ALCL)
PDF, 2.19MB

This National Guideline sets out a standardised approach to the diagnosis, treatment and follow-up of BIA-ALCL. It provides the necessary information to support the identification of symptoms, manage an initial presentation, perform a clinical examination and summarises best practice for anyone presenting with the symptoms associated with BIA-ALCL.

Back to HSE National Central Repository